| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |